52 Week Range 66.54 20.66 Day Range 52.42 51.03 ● eps (fwd) -0.82 PE . Div Rate . Yield Short Interest 5.02% Market Cap $2.07B Volume 172,598 Prev. Close $52.16 David Trood RtsSight, Inc. (NASDAQ:RXST) is a pioncering medical technology company dedicated to transforming the cataract surgery landscape. The company's flagship rectual online (10,000 (0.101) posted, is the first and only FDA-approved premium intraocular clargest, mocendar. margesty, anto compary, v mbosmper in viagampe vindeming m and unparalle ...

RxSight, Inc. (RXST) closed the last trading session at $50.73, gaining 6.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $64.75 indicates a 27.6% upside potential. The mean estimate comprises eight short-term price targets with a standard deviation of $7.92. While the lowest estimate of $54 indicates a 6.5% increase from the current price level, the most optimistic analyst expe ...

RxSight, Inc. (NASDAQ:RXST) Q2 2024 Earnings Conference Call August 5, 2024 4:30 PM ET Company Participants Ron Kurtz - President, Chief Executive Officer Shelley Thunen - Assistant Secretary, Chief Financial Officer Oliver Moravcevic - Vice President, Investor Relations Conference Call Participants Ryan Zimmerman - BTIG Robbie Marcus - J.P. Morgan Steven Lichtman - Oppenheimer & Co. Inc. David Saxon - Needham & Company Craig Bijou - Bank of America Larry Biegelsen - Wells Fargo Tom Stephan - Stifel Operato ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40690 | --- | --- | |---------------------------------------------------------------------------------------|--------------------- ...

About RxSight, Inc. RxSight, Inc. is an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery. The RxSight® Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens® (LAL™/LAL+™, collectively the "LAL"), RxSight Light Delivery Device (LDD™) and accessories, is the first and only commercially available intraocular lens (IOL) technology that can be adjusted after surgery, enabling doctors to customize and deliver high ...

A downtrend has been apparent in RxSight, Inc. (RXST) lately with too much selling pressure. The stock has declined 16.1% over the past four weeks. However, given the fact that it is now in oversold territory and Wall Street analysts are majorly in agreement about the company's ability to report better earnings than they predicted earlier, the stock could be due for a turnaround. We use Relative Strength Index (RSI), one of the most commonly used technical indicators, for spotting whether a stock is oversol ...

Investor Relations Contact: Oliver Moravcevic VP, Investor Relations omoravcevic@rxsight.com RxSight, Inc. is an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery. The RxSight® Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens® (LAL®/LAL+™, collectively the "LAL"), RxSight Light Delivery Device (LDD™) and accessories, is the first and only commercially available intraocular lens (IOL) technology that can ...

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In the 'long' context, investors will be essentially be "buying high, but hoping to sell even higher." With this methodology, taking advantage of trends in a stock's price is key; once a stock establishes a course, it is more than likely to continue moving that way. The goal is that once a stock heads down a fixed path, it will lead to timely and profitable trades. Even though momentum is a popular stock cha ...

RxSight, Inc. (NASDAQ:RXST) Q1 2024 Earnings Conference Call May 6, 2024 4:30 PM ET Company Participants Oliver Moravcevic – Vice President, Investor Relations Ron Kurtz – President and Chief Executive Officer Shelley Thunen – Chief Financial Officer Conference Call Participants Robbie Marcus – JPMorgan Ryan Zimmerman – BTIG Patrick Wood – Morgan Stanley David Saxon – Needham & Company Tom Stephan – Stifel Larry Biegelsen – Wells Fargo Steve Lichtman – Oppenheimer & Co. Operator Good day and thank you for s ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40690 RxSIGHT, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 94-3268801 (State or other jurisdiction of (I ...